HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $337,274 | +5.0% | 327,450 | +18.2% | 0.48% | +31.5% |
| Q2 2023 | $321,337 | -34.9% | 277,015 | -15.2% | 0.36% | -37.0% |
| Q1 2023 | $493,252 | -26.1% | 326,657 | +22.3% | 0.58% | -29.3% |
| Q4 2022 | $667,570 | -33.9% | 267,028 | +11.6% | 0.81% | -25.9% |
| Q3 2022 | $1,010,000 | +100.0% | 239,346 | +32.2% | 1.10% | +115.1% |
| Q2 2022 | $505,000 | -35.7% | 181,010 | +31.9% | 0.51% | +6.7% |
| Q1 2022 | $785,000 | +42.5% | 137,255 | +127.4% | 0.48% | +94.3% |
| Q4 2021 | $551,000 | -18.4% | 60,358 | -4.3% | 0.25% | +0.4% |
| Q3 2021 | $675,000 | +3.5% | 63,098 | +50.2% | 0.24% | +14.0% |
| Q2 2021 | $652,000 | +82.6% | 42,000 | +90.9% | 0.22% | +55.8% |
| Q1 2021 | $357,000 | -23.4% | 22,000 | 0.0% | 0.14% | -60.9% |
| Q4 2020 | $466,000 | – | 22,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |